Picard Medical is trading at $9.70, up +10.23%, despite broader weakness in major U.S. indices; today’s catalyst remains unclear.

  • No new Picard Medical company-specific announcement was identified for August 28–31, 2026.
  • The latest official release was the August 19, 2026 second-quarter report.
  • Recent volatility followed the report and 1-for-50 reverse stock split, but neither directly explains August 31’s move.